Many promising innovations from a vast array of sectors - including medicine, agriculture, engineering, computer science and energy have received CAS funding.
Sustainable conversion of agricultural wastes into high value functional materials - Phil Kwong
Growing concern over sustainable agricultural practices and environmental pollution have stimulated high demand for cost effective organic fertilizers and functional materials for environmental remediation. This technology will utilize waste resources for simultaneous clean energy and high vale functional material, e.g. activated carbon.
The generation of antibodies to cell surface HSC70 - Andrew Zannettino, Stan Gronthos, Stephen Fitter
The STRO-1 monoclonal antibody is recognised as identifying human mesenchymal stem cells which are located in tooth roots and are able to differentiate in to bone, muscle, fat or cartilage cells. The aim of this project is do create selective antibodies which will be able to isolate these stem cells with the greatest “stem-like” properties.
A GLAS technology to create non-toxic coloured glass by controlling the formation of metallic nanoparticles - Yunle Wei, Heike Ebendorff-Heidepriem, Jiangbo (Tim) Zhao
The traditional process of colouring glass revolves around adding metal nanoparticle and toxic compounds which pose a constant potential hazard on emission or evaporation to human health and environment. . In response we have developed the GLAS technology, which is Green (nontoxic and energy saving), Large-scale (mass production), All-in-one (colour codes and dichroic effect created by embedding various noble metal nanoparticles), and Simple (easy manufacturing process)
A new medicated surgical hydrogel to improve wound healing after endoscopic sinus surgery - Sarah Vreugde, PJ Wormald, Katharina Richter
This project presents an innovative strategies to prevent the adhesion of multi-drug resistant bacteria to the sinus lining post-surgery with an anti-adhesive surgical hydrogel. The patent protected gel has good biocompatibility, is non-toxic, promotes haemostasis and is an excellent drug delivery device.
Illegal timber import screening services - Andrew Lowe, Eleanor Dornmott
Illegally traded timber causes global damages of USD198 billion per year in terms of lost income to local economies, carbon emissions and biodiversity. Recent law changes which criminalise illegally sourced timber provide an opportunity to have a DNA screening databases to assess legally of timber imports.
International expansion of new Australian almond varieties - Michelle Wirthensohn
Australia is the world’s third largest almond produce, with the Australian almond breeding program based at the University delivering five new varieties into the Australian market, and a sixth soon to be released. The six varieties of almonds will be exported as a package in to new markets of Spain, USA, Italy and the emerging South African market with goals to pass quarantine and grow in test field sites in all these countries.
Robotic testing system for dynamic 3D manipulation - Boyin Ding
The 6DOF hexapod robot is a robot framework capable of achieving micro-order precision even under tonnes of external loading. The control system of the robot was designed to meet various three-dimensional test criteria, including a dynamic 6DOF load control system to replicate physiological loading on the test sample, to better understand human joints for the future of artificial limbs and implants.
Cancer cell detector - Erik Schartner
With 15-20% of breast cancer surgery patients requiring additional surgery to further remove tumorous tissue, there is a need for improved surgical practices that can also provide enhanced cosmetic outcomes. This technology offers a novel detection tool using optical fibre sensors that will differentiate between cancerous and normal tissues based on pH levels, to provide specific, real time information to surgeons.
Smart needles for brain surgery - Rob McLaughlin
A novel miniaturized imaging probe, so small that it can be encased within a hypodermic needle for use in neurosurgery, enables safer and more effective brain biopsies. Having already progressed this product to initial human in vivo studies, this high tech medical device is ready to through the regulatory pathways, to service an estimated $200m market, creating new employment opportunities in South Australia, and better neurosurgery outcomes globally.
Treatment of coronary slow flow phenomenon - John Beltrame
Patients with signs of coronary slow flow phenomenon (or CSFP) experience frequent and recurrent chest pains causing major impairment of quality of life and high healthcare resource utilization. The investigators have proposed a randomised, double-blind, placebo-controlled crossover study, utilising an existing drug which is proposed to be repurposed, to reduce the symptoms of CSFP.
Intelligent infrared vision sensors - Martin O'Connor
This technology integrates the see through capabilities of short wave infrared sensors with emerging big data analytics and machine learning algorithms. The result is object recognition and obstacle avoidance capabilities, to transform awareness into understanding, adding context and insight for application in the battlefield and beyond.
Photocatalytic transformation of CO2 and H2O - Greg Metha
A unique approach to “unburn” CO2 using metal cluster technology and artificial photosynthesis to produce ready to use, drop in fuels, without the need for added chemicals or processing. This technology offers the combined benefits of zero carbon solar energy harvesting, energy storage and CO2 emissions reduction.
Improving the success of human IVF - Mark Nottle
It is well known that the demand for human IVF is increasing, however success rates in the industry remain low (with c. 20% of treatments resulting in a live baby). This project proposes to introduce a known and naturally occurring molecule to in vitro maturation media, to replicate the in vivo environment, and enhance the efficacy of the overall human IVF process.
- Commercial development of a novel intraceullular based vaccine for the prevention of Apicomlexan parasitic diseases and other intracellular pathogens – Dr Ryan O’Handley
- A novel Parkinson’s disease therapy using AstraZeneca’s Saracatinib (AZD0530) to inhibit Fyn kinase – Dr Lyndsey Collins-Praino
- Mucositis therapy with AstraZeneca’s AZD1236 – Associate Professor Rachel Gibson
- Spin out, CarbOzide Pty Ltd – Professor Vincent Bulone
- Next-generation photonic magnetic sensing for geophysical exploration – Professor Andre Luiten
- A new formulation of embryo production media for cattle in vitro embryo production – Associate Professor Jeremy Thompson